PRESTIGE BIOPHARMA
IN ONE-NORTH
SINGAPORE
PRESTIGE BIOPHARMA IDC
IN BUSAN,
KOREA
PRESTIGE BIOLOGICS
IN OSONG BIOCLUSTER,
KOREA
First-in-Class
Development of First-in-Class therapeutics for unmet diseases
Biosimilars
Prominent biosimilar pipelines for accelerating market access
Diagnostics
Diagnostics for Pancreatic Cancer by detecting PAUF
-
CPHI Milan 2024
Event Dates: Oct 8 ( Mon ) - Oct 10 (wed), 2024 개최 장소 : Fiera MilanoCity/Country : Milan / ItalyWebsite : www.cphi.com/europeRESERVATIONThank you for your interest in exploring potential opportunities with us.Please indicate your preferred timeslot for an in-person meeting and specify the topic you would like to discuss.Once we receive your request, we will reach out to you to confirm the suitable timeslot andthe company delegate who will be attending. [ameliastepbooking service=2]INQUIRET. +65 6924 6535 E. info@prestigebio.comPrestige Biopharma Group Participates in BIO USA 2024 Exhibition
BIO USA 2024 has opened today in the United States. Prestige Biopharma Group is continuing with over 30 meetings on the first day.All employees are committed to doing their best to achieve successful outcomes.Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
BIO USA 2024 has opened today in the United States. Prestige Biopharma Group is continuing with over 30 meetings on the first day.All employees are committed to doing their best to achieve successful outcomes.BIO International Convention 2024 - Prestige Biopharma IDC
BIO International Convention 2024 - Prestige Biopharma IDCEvent Dates: June 3 to 6, 2024Venue: San Diego Convention Center, CaliforniaWebsite: www.convention.bio.orgPartnering Schedule:June 3: 1:00pm to 6:00pmJune 4: 10:30am to 5:00pmJune 5: 10:30am to 6:00pmJune 6: 10:30am to 4:30pmRESERVATIONThank you for your interest in exploring potential opportunities with us.Please indicate your preferred timeslot for an in-person meeting and specify the topic you would like to discuss.Once we receive your request, we will reach out to you to confirm the suitable timeslot andthe company delegate who will be attending. [wpforms id="5217" title="false"]INQUIRET. +65 6924 6535 E. info@prestigebio.comBIO International Convention 2024 - Prestige Biopharma
BIO International Convention 2024 - Prestige BiopharmaEvent Dates: June 3 to 6, 2024Venue: San Diego Convention Center, CaliforniaWebsite: www.convention.bio.orgPartnering Schedule:June 3: 1:00pm to 6:00pmJune 4: 10:30am to 5:00pmJune 5: 10:30am to 6:00pmJune 6: 10:30am to 4:30pmRESERVATIONThank you for your interest in exploring potential opportunities with us.Please indicate your preferred timeslot for an in-person meeting and specify the topic you would like to discuss.Once we receive your request, we will reach out to you to confirm the suitable timeslot andthe company delegate who will be attending. [wpforms id="5153" title="false"] INQUIRET. +65 6924 6535 E. info@prestigebio.comPrestige Biologics enters into MoU with Aurigene Pharmaceutical Services Limited to explore collaboration in CDMO market
Prestige Biologics enters into MoU with Aurigene Pharmaceutical Services Limited to explore collaboration in the global biologics CDMO marketPrestige Biologics, a Contract Development and Manufacturing Organization (CDMO) specializing in biopharmaceuticals, announced the establishment of a strategic partnership with Aurigene Pharmaceutical Services Limited (APSL), a wholly owned step-down subsidiary company of Dr. Reddy’s Laboratories Limited, through the signing of a non-binding Memorandum of Understanding (MoU). The MoU, which is subject to a Definitive Agreement, will oversee collaborative efforts between Prestige Biologics and APSL to bring in a comprehensive set of services and capabilities towards meeting the CDMO needs of biologics-focused companies. “We are delighted to announce our strategic partnership with Aurigene Pharmaceutical Services Limited,” stated Duk Hoon Hyun, CEO of Prestige Biologics. “Prestige Biologics’ global prominence in the CDMO market, coupled with Aurigene’s pharmaceutical expertise in R&D services, will create an end-to-end service capability in the Biologics CRDMO segment through this collaboration, offering cell line development to large-scale manufacturing services for global Biologics customers.”Aurigene Pharmaceutical Services Limited is a Contract Research, Development and Manufacturing Organization (CRDMO) with end-to-end capabilities across drug discovery, development, and manufacturing of small and large molecules. Dr. Reddy’s Laboratories Limited, the parent company of APSL, is a global pharmaceutical company, founded in 1984, with four decades of expertise in pharmaceutical development, and a global commercial network. Prestige Biologics operates production facilities based in South Korea, with a manufacturing capacity of 154,000 litres, making Prestige Biologics one of the top 10 global CDMO companies working with animal cell culture.